Vaccine Candidate Gets Orphan Drug Status for Glioblastoma Treatment
The Food and Drug Administration (FDA) has granted Orphan Drug designation to VBI-1901 for the treatment of glioblastoma. Glioblastoma is a rare, aggressive, malignant grade IV brain tumor that develops from the glial cells. VBI-1901…